🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Teva Branded Pharmaceutical Products R&D clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our USA and UK registers with Teva Branded Pharmaceutical Products R&D as lead sponsor. Synced 26 Sep 2026
9Current trials
5Recruiting now
3Drugs in these trials
2Trial registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Teva Branded Pharmaceutical Products R&D is the lead sponsor of 9 current clinical trials in our USA and UK registers. 5 are recruiting patients now. The most common phase is Phase 2. The drugs named most often in its trials are TEV-56286, TEV-53408 and Pembrolizumab. The most-studied condition is Multiple System Atrophy.

ClinicalTrials.gov trials by status

  • Recruiting556%
  • Active, closed444%

Trials by phase

  • Phase 2444%
  • Phase 1333%
  • Phase 3222%
01

Clinical trials sponsored by Teva Branded Pharmaceutical Products R&D

9 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy
NCT07197866 · ClinicalTrials.gov ↗ · Multiple System Atrophy
Drug: TEV-56286
Phase 2 Recruiting 2025-09 USA
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
NCT06664619 · ClinicalTrials.gov ↗ · Asthma
Phase 3 Recruiting 2024-12 USA
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
NCT06568237 · ClinicalTrials.gov ↗ · Multiple System Atrophy
Drug: TEV-56286
Phase 2 Recruiting 2024-10 USA
A Trial to Assess TEV-56286 at Different Doses in Healthy Participants
NCT07674940 · ClinicalTrials.gov ↗ · Healthy Volunteers
Drug: TEV-56286
Phase 1 Recruiting 2026-06 USA
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
NCT06480552 · ClinicalTrials.gov ↗ · Advanced Solid Tumors
Phase 1 Recruiting 2024-07 USA
A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
NCT05668013 · ClinicalTrials.gov ↗ · Crohn Disease, Colitis, Ulcerative
Phase 2 Active, closed 2023-01 UK, USA
A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease
NCT06807463 · ClinicalTrials.gov ↗ · Celiac Disease
Drug: TEV-53408
Phase 2 Active, closed 2025-03 USA
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
NCT06052267 · ClinicalTrials.gov ↗ · Asthma
Phase 3 Active, closed 2023-08 USA
A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With Vitiligo
NCT06625177 · ClinicalTrials.gov ↗ · Vitiligo
Drug: TEV-53408
Phase 1 Active, closed 2024-11 USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Teva Branded Pharmaceutical Products R&D trials

3 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Teva Branded Pharmaceutical Products R&D trials

8 conditions
04

By trial register

RegisterTrialsRecruiting
Clinical trials in USA95
Clinical trials in UK10

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Multiple System Atrophy

SponsorTrials
H. Lundbeck3
Tiziana Life Sciences1
yilong Wang1

Sponsors with the most current trials registered for this condition.

06

Questions about Teva Branded Pharmaceutical Products R&D trials

How many clinical trials does Teva Branded Pharmaceutical Products R&D sponsor?

Teva Branded Pharmaceutical Products R&D is the lead sponsor of 9 current trials on ClinicalTrials.gov in our USA and UK registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Teva Branded Pharmaceutical Products R&D trials recruiting?

Yes. 5 of its 9 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Teva Branded Pharmaceutical Products R&D testing?

Its current trials name 3 drugs and biologicals as interventions. The most frequent are TEV-56286 (3), TEV-53408 (2) and Pembrolizumab (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.